BridgeMD
New treatment option for Anxiety Disorders
Official title Reducing Mental Health Disparities Among Latinxs With a Telenovela Intervention
ClinicalTrials.gov ID: NCT06163599
What this study is testing
- What it's testing
- The primary aim of our study is to determine the effectiveness of an transdiagnostic telenovela video intervention in reducing anxiety and depressive symptoms using a pre/post-test design with Spanish-speaking Latinxs.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- 18 years or older
- Identify as Latinx
- Prefer behavioral health services in Spanish
- Meet the DSM criteria for any mild to moderate anxiety disorder
- Ownership of a smartphone
You likely can't join if
- Suicidality
- Psychosis
- Bipolar disorder
- Severe anxiety disorders
- Severe depressive disorders
- Homicidality
The study team makes the final eligibility decision.
Where it's taking place
- Reno, Nevada, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Reno, Nevada, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.